HX Diagnostics lands $3.1M to diagnose infectious disease
Biotech firm HX Diagnostics, based in Emeryville, Calif., has raised $3.12 million in a first round of funding from Kleiner Perkins Caufield & Byers, Nanogen and Xiamen YST Biotech, reports peHUB. The company says its mission is to develop rapid diagnostics for seasonal and emerging infectious diseases, partcularly different strains of influenza.
Next Story: Alios nabs $8.4M to treat viruses
Previous Story: GDC 09: conference to reflect a more global game industry
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
